Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.

James, Nicole E; Valenzuela, Ashley D; Emerson, Jenna B; Woodman, Morgan; Miller, Katherine; Hovanesian, Virginia; Ou, Joyce; Ribeiro, Jennifer R

James, Nicole E; Valenzuela, Ashley D; Emerson, Jenna B; Woodman, Morgan; Miller, Katherine; Hovanesian, Virginia; Ou, Joyce; Ribeiro, Jennifer R.

Afiliação

James NE; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI 02903, USA.
Valenzuela AD; Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Emerson JB; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI 02903, USA.
Woodman M; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI 02903, USA.
Miller K; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI 02903, USA.
Hovanesian V; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI 02903, USA.
Ou J; Rhode Island Hospital, Core Research Laboratories, Women and Infants Hospital, Providence, RI 02903, USA.
Ribeiro JR; Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.

Oncol Lett ; 23(6): 188, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35527785